Strict Action Against Illegal Distribution of Gardasil Vaccine Announced by the Food and Drug Administration
The Food and Drug Administration (FDA) issued a statement emphasizing that the distribution of the Gardasil vaccine, which prevents cancers caused by the HPV virus, must occur exclusively through authorized channels and selected pharmacies. The FDA warned that any sales outside these official routes constitute a violation, and the organization will take strict action against such offenses.
Reports of Illegal Distribution and Online Promotions
According to the FDA, the Gardasil vaccine enters the country through formal channels and is registered in the T-TAC system. However, reports have emerged of unauthorized distribution in private clinics and unofficial centers, as well as misleading advertisements and illegal sales online. These violations not only jeopardize public health but also disrupt equitable access to the vaccine and artificially inflate prices.
Legal Measures and Tightened Oversight
The FDA has forwarded multiple cases to legal authorities and referred certain violations to the Cyber Police (FATA). It revealed that some individuals, through false advertising, have sought to create artificial demand and sell vaccines outside the legal network. Such actions have disrupted the fair distribution process, creating barriers to community-wide vaccine access.
To prevent recurring violations, the FDA pledged to intensify monitoring efforts across the vaccine distribution chain. This includes stricter oversight of pharmacies and precise documentation of vaccine consumer data, ensuring that illegal practices do not impact the market or hinder fair access.
Transparent Pricing and Reporting Violations
The FDA emphasized that the prices of all medicines and vaccines, including Gardasil, are available to the public via the T-TAC system. This system serves as the official reference for registering and pricing medications and vaccines, and any sales outside this framework are considered illegal.
Public health and equitable vaccine distribution remain top priorities for the FDA, which assured decisive action against violators. The FDA also urged citizens to report any suspected cases of illegal vaccine distribution through its designated communication channels.
4o
